Apixaban PK pecularities [PK / PD]

posted by BE-proff – 2022-03-14 21:17 (1555 d 19:43 ago) – Posting: # 22836
Views: 4,680

Hi All,

According to Apixaban PIL its kinetics has some peculiarities::lookaround:

1) AUC is 32% higher in patients aged over 65
2) AUC is 18% higher in women
3) AUC is 30% higher in patients with body weight below 50 kilos.

Will it be correct to say (using extrapolation) that if a slim woman aged 70 takes 2.5 mg of apixaban the "actual dose" is close to 5.0 mg? :confused:

From the point of safety the question is important :wink:

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
142 visitors (0 registered, 142 guests [including 11 identified bots]).
Forum time: 18:01 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5